Trials / Unknown
UnknownNCT03738605
Vaginal Laser Therapy in Breast Cancer Survivors
Vaginal Laser Therapy for the Management of Genitourinary Syndrome of Menopause of Breast Cancer Survivors: Double-blind Randomized Placebo-controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- National and Kapodistrian University of Athens · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study evaluates the efficacy of vaginal CO2 laser therapy in breast cancer survivors with symptoms of Genitourinary Syndrome of Menopause. Half of participants will receive active laser therapy, while the other half placebo therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Microablative Fractional CO2 Laser Therapy | 5 laser therapies intravaginally administered will be applied at monthly intervals. |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2020-06-01
- Completion
- 2020-08-01
- First posted
- 2018-11-13
- Last updated
- 2019-07-30
Locations
1 site across 1 country: Greece
Source: ClinicalTrials.gov record NCT03738605. Inclusion in this directory is not an endorsement.